Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

Customizing medications can be lifesaving and also dangerous. Understand the advantages and disadvantages of Compounding ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

A study that looked at insights from the S&P's Global Financial Literacy Survey found that "consumers who fail to understand the concept of interest compounding spend more on transaction fees ...